Drug
Futuximab Modotuximab
Futuximab Modotuximab: highest development phase Phase 3, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| Futuximab/modotuximab NCT05223673 | Phase 3 | Metastatic Colorectal Cancer |
Latest
No recent events.
Follow Futuximab Modotuximab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.